Skip to content
value.today

SnapMedTech, Inc.

🇺🇸 Atlanta, Georgia, USATechnologyFounded 2017
Total raised
$19 M
2 rounds on record
Latest round
$18 M
Aug 2021
First round on record
Aug 2017
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of SnapMedTech, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Aug 2021$18 MNo. 2$10 to $50 million

SnapMedTech, Inc.: Raise no. 2, Aug 2021

Investors in this round

63 investors had bought by the notice of Oct 14, 2021: 63 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$18 M of $18 M offered
Smallest investment taken
$11,112
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Cherie Kloss · Executive Officer, Director
  • David Burton · Executive Officer
  • Jeff Richards · Executive Officer, Director
  • John Spears · Executive Officer
  • Kirk Martin · Executive Officer, Director
  • Mark Brown · Executive Officer
  • Sean Hammond · Executive Officer, Director
  • Francis Najafi · Director
  • Tuan Bui · Director
  • Tyler Rives · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Sean Hammond, Cfo. Source: SEC Form D, newest notice filed Oct 14, 2021. Read the notice at the SEC.

equitySEC
Aug 2017$1 MNo. 1Under $2 million

SnapMedTech, Inc.: Raise no. 1, Aug 2017

Investors in this round

20 investors had bought by the notice of Aug 24, 2017: 20 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
$25,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$175,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Cherie Kloss · Executive Officer, Director
  • Mark Brown · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Cherie Kloss, Ceo. Source: SEC Form D, newest notice filed Aug 24, 2017. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • SnapMedTech, Inc. chose not to state its revenue in its newest notice of a funding round (Oct 2021).

    SEC Form D · Oct 2021

  • The industry group it chose in its notices: Other Technology.

    SEC Form D · Oct 2021

That is all the official record says: SnapMedTech, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of SnapMedTech, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 63 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by SnapMedTech, Inc.
NameRoleNamed in
Cherie KlossExecutive officerOct 2021
David BurtonExecutive officerOct 2021
Jeff RichardsExecutive officerOct 2021
John SpearsExecutive officerOct 2021
Kirk MartinExecutive officerOct 2021
Mark BrownExecutive officerOct 2021
Sean HammondExecutive officerOct 2021
Cherie KlossDirectorOct 2021
Francis NajafiDirectorOct 2021
Jeff RichardsDirectorOct 2021
Kirk MartinDirectorOct 2021
Sean HammondDirectorOct 2021
Tuan BuiDirectorOct 2021
Tyler RivesDirectorOct 2021
Mark BrownDirectorAug 2017